Intravascular Imaging of Atherosclerosis by Using Engineered Nanoparticles

Author:

Li Jiawen123ORCID,Centurion Franco4ORCID,Chen Rouyan13,Gu Zi456ORCID

Affiliation:

1. School of Electrical and Mechanical Engineering, University of Adelaide, Adelaide, SA 5005, Australia

2. Australian Research Council Centre of Excellence for Nanoscale BioPhotonics, Adelaide, SA 5005, Australia

3. Institute for Photonics and Advanced Sensing, The University of Adelaide, Adelaide, SA 5005, Australia

4. School of Chemical Engineering, University of New South Wales, Sydney, NSW 2052, Australia

5. Australian Centre for NanoMedicine (ACN), University of New South Wales, Sydney, NSW 2052, Australia

6. UNSW RNA Institute, University of New South Wales, Sydney, NSW 2052, Australia

Abstract

Atherosclerosis is a leading cause of morbidity and mortality, and high-risk atherosclerotic plaques can result in myocardial infarction, stroke, and/or sudden death. Various imaging and sensing techniques (e.g., ultrasound, optical coherence tomography, fluorescence, photoacoustic) have been developed for scanning inside blood vessels to provide accurate detection of high-risk atherosclerotic plaques. Nanoparticles have been utilized in intravascular imaging to enable targeted detection of high-risk plaques, to enhance image contrast, and in some applications to also provide therapeutic functions of atherosclerosis. In this paper, we review the recent progress on developing nanoparticles for intravascular imaging of atherosclerosis. We discuss the basic nanoparticle design principles, imaging modalities and instrumentations, and common targets for atherosclerosis. The review is concluded and highlighted with discussions on challenges and opportunities for bringing nanoparticles into in vivo (pre)clinical intravascular applications.

Funder

National Health and Medical Research Council

National Heart Foundation of Australia

Australian Research Council

NSW Cardiovascular Research Capacity Program Early-Mid Career Researcher Grant

Publisher

MDPI AG

Subject

Clinical Biochemistry,General Medicine,Analytical Chemistry,Biotechnology,Instrumentation,Biomedical Engineering,Engineering (miscellaneous)

Reference107 articles.

1. World Health Organization (2002). The World Health Report 2002–Reducing Risks, Promoting Healthy Life, World Health Organization.

2. Heart Disease and Stroke Statistics-2018 Update: A Report from the American Heart Association;Benjamin;Circulation,2018

3. Vulnerable plaques and patients: State-of-the-art;Tomaniak;Eur. Heart J.,2020

4. Multimodality Intravascular Imaging of High-Risk Coronary Plaque;Li;JACC Cardiovasc. Imaging,2022

5. A Prospective Natural-History Study of Coronary Atherosclerosis;Stone;N. Engl. J. Med.,2011

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3